Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12768254 | 0.88 | ALDH1A1 (0.58) | L3MBTL1ALDH1A1NPSR1LMNAGAA | |
| SCHEMBL6404676 | 0.81 | L3MBTL1 (0.62) | L3MBTL1ALDH1A1NPSR1POLBLMNA | |
| SCHEMBL6411070 | 0.81 | L3MBTL1 (0.62) | L3MBTL1ALDH1A1NPSR1POLBLMNA | |
| SCHEMBL11391926 | 0.80 | KMT2A (0.49) | L3MBTL1ALDH1A1NPSR1LMNAHTT | |
| SCHEMBL11384854 | 0.80 | TLR8 (0.44) | L3MBTL1ALDH1A1NPSR1LMNAHTT | |
| SCHEMBL6402514 | 0.77 | OXTR (0.57) | ALDH1A1NPSR1HTTUSP2HPGD | |
| SCHEMBL11887412 | 0.77 | VCP (0.61) | NPSR1HTTMAPTPKM | |
| SCHEMBL2551450 | 0.75 | OXTR (0.56) | L3MBTL1ALDH1A1POLBLMNAHTT | |
| SCHEMBL11996348 | 0.75 | L3MBTL1 (0.42) | L3MBTL1ALDH1A1NPSR1POLBLMNA | |
| SCHEMBL6405035 | 0.74 | MAPT (0.53) | ALDH1A1POLBLMNAHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | AGRIUS GROUP, LLC. | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | ABCG2, ATP5ME, DNTT | L3MBTL1 2749/4885ALDH1A1 720/4885NPSR1 4536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.